NUR 550 Topic 2 DQ 1 Explain the value of biostatistics in population health research

Grand Canyon University NUR 550 Topic 2 DQ 1 Explain the value of biostatistics in population health research-Step-By-Step Guide

This guide will demonstrate how to complete the Grand Canyon University NUR 550 Topic 2 DQ 1 Explain the value of biostatistics in population health research assignment based on general principles of academic writing. Here, we will show you the A, B, Cs of completing an academic paper, irrespective of the instructions. After guiding you through what to do, the guide will leave one or two sample essays at the end to highlight the various sections discussed below.

How to Research and Prepare for NUR 550 Topic 2 DQ 1 Explain the value of biostatistics in population health research                       

Whether one passes or fails an academic assignment such as the Grand Canyon University NUR 550 Topic 2 DQ 1 Explain the value of biostatistics in population health research depends on the preparation done beforehand. The first thing to do once you receive an assignment is to quickly skim through the requirements. Once that is done, start going through the instructions one by one to clearly understand what the instructor wants. The most important thing here is to understand the required format—whether it is APA, MLA, Chicago, etc.

After understanding the requirements of the paper, the next phase is to gather relevant materials. The first place to start the research process is the weekly resources. Go through the resources provided in the instructions to determine which ones fit the assignment. After reviewing the provided resources, use the university library to search for additional resources. After gathering sufficient and necessary resources, you are now ready to start drafting your paper.

How to Write the Introduction for NUR 550 Topic 2 DQ 1 Explain the value of biostatistics in population health research                       

The introduction for the Grand Canyon University NUR 550 Topic 2 DQ 1 Explain the value of biostatistics in population health research is where you tell the instructor what your paper will encompass. In three to four statements, highlight the important points that will form the basis of your paper. Here, you can include statistics to show the importance of the topic you will be discussing. At the end of the introduction, write a clear purpose statement outlining what exactly will be contained in the paper. This statement will start with “The purpose of this paper…” and then proceed to outline the various sections of the instructions.

How to Write the Body for NUR 550 Topic 2 DQ 1 Explain the value of biostatistics in population health research                       

After the introduction, move into the main part of the NUR 550 Topic 2 DQ 1 Explain the value of biostatistics in population health research  assignment, which is the body. Given that the paper you will be writing is not experimental, the way you organize the headings and subheadings of your paper is critically important. In some cases, you might have to use more subheadings to properly organize the assignment. The organization will depend on the rubric provided. Carefully examine the rubric, as it will contain all the detailed requirements of the assignment. Sometimes, the rubric will have information that the normal instructions lack.

Another important factor to consider at this point is how to do citations. In-text citations are fundamental as they support the arguments and points you make in the paper. At this point, the resources gathered at the beginning will come in handy. Integrating the ideas of the authors with your own will ensure that you produce a comprehensive paper. Also, follow the given citation format. In most cases, APA 7 is the preferred format for nursing assignments.

How to Write the Conclusion for NUR 550 Topic 2 DQ 1 Explain the value of biostatistics in population health research                       

After completing the main sections, write the conclusion of your paper. The conclusion is a summary of the main points you made in your paper. However, you need to rewrite the points and not simply copy and paste them. By restating the points from each subheading, you will provide a nuanced overview of the assignment to the reader.

How to Format the References List for NUR 550 Topic 2 DQ 1 Explain the value of biostatistics in population health research                       

The very last part of your paper involves listing the sources used in your paper. These sources should be listed in alphabetical order and double-spaced. Additionally, use a hanging indent for each source that appears in this list. Lastly, only the sources cited within the body of the paper should appear here.

Stuck? Let Us Help You

Completing assignments can sometimes be overwhelming, especially with the multitude of academic and personal responsibilities you may have. If you find yourself stuck or unsure at any point in the process, don’t hesitate to reach out for professional assistance. Our assignment writing services are designed to help you achieve your academic goals with ease. 

Our team of experienced writers is well-versed in academic writing and familiar with the specific requirements of the NUR 550 Topic 2 DQ 1 Explain the value of biostatistics in population health research assignment. We can provide you with personalized support, ensuring your assignment is well-researched, properly formatted, and thoroughly edited. Get a feel of the quality we guarantee – ORDER NOW. 

Sample Answer for NUR 550 Topic 2 DQ 1 Explain the value of biostatistics in population health research Included After Question

Explain the value of biostatistics in population health research. Describe the role of epidemiology in researching and addressing population health challenges. How are epidemiology and biostatistics significant to your evidence-based practice proposal?

A Sample Answer For the Assignment: NUR 550 Topic 2 DQ 1 Explain the value of biostatistics in population health research

Title: NUR 550 Topic 2 DQ 1 Explain the value of biostatistics in population health research

Biostatisticians study diseases and potential behaviors and health risks for the local environment (The University of Nevada, 2020). Biostatisticians utilize research like qualitative and quantitative studies to research certain public health risks related to the local environment and attempt to provide information on how these problems can be addressed and eradicated in the area (The University of Nevada, 2020). There are several things that biostatistics research does in the Public Health realm including environmental factors, cancer research, statistical genetics, and human growth and development (The University of Nevada, 2020). Epidemiology focuses most on how and entire population is affected utilizing distribution and determination (The University of Nevada, 2020). With Distribution they are looking at the frequencies of disease processes and the trends in an area (The University of Nevada, 2020). With determination they look at cause and effect, risk factors and any underlying causes (The University of Nevada, 2020). Epidemiologists focus on areas like infectious diseases, environmental issues, noninfectious diseases, injuries, natural disasters and acts of terror (The University of Nevada, 2020). My personal project proposal involved the epidemiology of Syphilis and its rampant spread through Alaska (Berman, 2020). The epidemiology of the spread of this STD shifted since 2019 into 2020 and has spread even faster than before, due to the nursing focus being on Covid-19 patients (Berman, 2020).

The University of Nevada, Reno. (2020, November 17). Epidemiology vs. Biostatistics: Understanding Their Roles in Public Health. University of Nevada, Reno. https://onlinedegrees.unr.edu/blog/epidemiology-vs-biostatistics/

Berman, A. (2020, July 31). Alaska’s syphilis cases more than doubled in a year, and COVID-19 has complicated outbreak response. Anchorage Daily News. https://www.adn.com/alaska-news/2020/07/30/alaskas-syphilis-cases-have-doubled-in-the-past-year-and-covid-19-has-complicated-outbreak-response/#:%7E:text=The%20state’s%20syphilis%20outbreak%20was,in%20heterosexual%20men%20and%20women.

A Sample Answer 2 For the Assignment: NUR 550 Topic 2 DQ 1 Explain the value of biostatistics in population health research

Title: NUR 550 Topic 2 DQ 1 Explain the value of biostatistics in population health research

I do agree with you that biostatistics and epidemiology help in qualitative and quantitative analysis of diseases hence provide crucial information for public health departments. It is crucial in developing the appropriate intervention measures that curb the spread of the disease and its fatality (Jackson et al., 2021). The department of health services in collaboration with other non- governmental

organizations are responsible for informing the members of the public on the epidemiology of number of health conditions. Some of the information shared by the epidemiologists often quantifies the disease by providing details on how many people are affected by a disease or a health condition. This quantifying process is a complex one and takes into account three critical measures of the disease, that is; frequency, prevalence, and incidence (MacDonald & Hsu, 2021). The aspect of frequency involves the counts of the people affected and it is achieved through carrying out disease surveillance. The prevalence of a disease refers to the proportion that gives a quick view of the population level disease burden at a given time (MacDonald & Hsu, 2021). The concept of incidence in epidemiology refers to the average risk of developing the disease over a period of time.

Click here to ORDER an A++ paper from our Verified MASTERS and DOCTORATE WRITERS: NUR 550 Topic 2 DQ 1 Explain the value of biostatistics in population health research

References

MacDonald, I., & Hsu, J.-L. (2021). Epidemiological observations on breaking COVID-19 transmission: from the experience of Taiwan. J Epidemiol Community Health. https://doi.org/10.1136/jech-2020-216240

Jackson, M. L., Ferdinands, J., Nowalk, M. P., Zimmerman, R. K., Kieke, B., Gaglani, M., Murthy, K., Petrie, J. G., Martin, E. T., Chung, J. R., Flannery, B., & Jackson, L. A. (2021). Differences between Frequentist and Bayesian inference in routine surveillance for influenza vaccine effectiveness: a test-negative case-control study. BMC Public Health, 21(1). https://doi.org/10.1186/s12889-021-10543-z

A Sample Answer 3 For the Assignment: NUR 550 Topic 2 DQ 1 Explain the value of biostatistics in population health research

Title: NUR 550 Topic 2 DQ 1 Explain the value of biostatistics in population health research

Re: Topic 2 DQ 1

Biostatistics, or the application of statistical analysis when developing, analyzing and improving population health studies, is essential to population health research. This is because the subfield of epidemiology focuses on disease progress and tracking over time, and how that impacts a population’s health (Weill Cornell Medicine, 2021). By effective collection, analysis and review of this information, clinicians, policy makers and community members can make more informed decisions on how to address a population’s biggest barriers to achieving high quality overall health.

In contrast, epidemiology is the study of what is upon the people. To be more specific, what causes health in a population, to ultimately understand how to utilize this knowledge to reduce the risk of illness and disease for the same group of people (Nash et. al, 2021). This is similar to the phrase population health, which has been identified by Garmon et. al as a model to review, disseminate information and take action to empower communities to be the healthiest they can be (2017). Epidemiology is an essential piece in researching and addressing population health challenges, because it allows for quantitative and qualitative study of a specific population’s health, how it has come to be, and understanding the data that supports the claim as evidence. By use of data and trend analysis, population health challenges can be combatted by way of focusing on key determinants of its health, and integrating policy, resources, education and other interventions as a way to improve the population’s overall health (Nash et. al, 2021).

Epidemiology and biostatistics are significant to my evidence-based practice proposal as I must utilize elements of biostatistics in understanding the emergency department stroke patient population. Additionally, epidemiology will assist me to understand how stroke impacts the community at large, and how it came to be one of the primary foci of community education and initiative across the United States. Ultimately, I look forward to developing a PICOT that addresses this gap in quality care for a critical and widespread patient population.

Also Check Out:  NUR 550 Topic 1 DQ 1 Identify the different levels of translational research

Biostatistics adds a significant value to population health by developing plans of care actions to keep the public safe and healthy. Population health is the distribution of health outcomes within a population, the determinants that influence distribution, and the policies and interventions that affect the determinants (Nash et.al. 2021). As defined by Minkoff (2022), biostatistics helps with the summarization of the characteristics of the sample and to test actions of a specific population that is being studied. The overall focus of biostatistics in a study is to explore something new about the population. Biostatistics help not only in health, medicines or nutrition but also in genetics, epidemiology, biology etc. Minkoff (2022) explains that biostatistics basically extracts the data received and makes valid inferences that are used to solve health challenges. The study method includes studying the sample of a specific population, reviewing the qualitative and quantitative data analysis. The work includes clinical trials, surveys, case studies, lab and field observations etc. to gather and analyze the data to draw conclusions.

“Epidemiology collects, analyzes, and interprets data regarding the distribution and determinants of disease among populations through descriptive epidemiology that focuses on the impact and extent of health-related events; and analytics epidemiology that focuses on searching the determinants of diseases” (Nash, 2016). When looking for a care/treatment/prevention for a specific disease process, it goes back to the causes (Nash, 2016). What causes the disease/outcome and what factors contribute to it, this is what is called a determinant. This way it helps with assessing and designing approaches to prevent diseases and improve the quality of life in the population. As described by CDC. (2016) in simpler term, Epidemiology is a way to find the causes of health outcomes and diseases in populations. It is the study (scientific, systematic, and data-driven) of the distribution (frequency, pattern) and determinants (causes, risk factors) of health-related states and events (not just diseases) in specified populations (neighborhood, school, city, state, country, global). It is often referred to as population medicine as it focuses on the health of individuals or groups of people.

Both biostatistics and epidemiology have a common goal of discovering these strategies with a slightly different approach. Population health improvements are stemmed from data from a variety of sources, that includes electronic medical records, population- based surveys, birth and death records, claim data and community input, expert opinion and many others (Nash, 2016).

My project is to improve the quality of care and reduce the rate of readmissions for congestive heart failure (CHF) patients. There are about 6.2 million adults in the United States that have health failure (HF) (CDC. 2023) The epidemiological and statistical data for heart failure provides information about disease process, causes, classification and stages of HF, risk prediction and prevention and treatment need. For example, HF study would elaborate on defining and adopting criteria to diagnose under consideration as well as classifying its severity for different stages of HF including the increasingly used entity of advanced HF, and of cardiac function. It also provides data on the study of disease across person, place and time (Veronique, 2021). This information would help in creating patients and diagnose specific care plans and education to CHF patient to improve care outcomes.

Research Framework and Legal and Ethical Translation

Before distributing the trial drug at the health fair, researchers ought to take into account the safety and efficacy of the medication to the target population. This implies that clear clinical experiments should have been conducted to guarantee safety in the use of the medication on human (Rosenblatt & Kuhlik, 2015). Most importantly, adverse events that arise from long term use of the drug should also be ascertained to gunner evidence on its value to human beings. However, the researchers need to ensure that their drug meets the regulatory standards and that they have a license that permits the use of the medication. Jarow et al. (2016) posit that prior to distribution of the drug, the researchers should identify the role of information and language based on the consumers. This implies that they must avail all the information about the drug related to usage, contraindication, and side effects. Such communication should be disseminated in a simple and concise language readily understood by the target audience. Clear information will also allow consumers to make a decision on the choice of the drug compared to alternative medications.

As part of the translational research team, I will ensure that our trial drug distribution meets the ethical standards outlined by the state (Rosenblatt & Kuhlik, 2015). In the second step, it will also be important for me to exhibit proper behavior with regard to the established code of ethics during our engagement with the consumers. For the third step, I will maintain diligence in the course of trial distribution. In other words, I will ensure that policies on ethical standards are enforced to improve team and community involvement as we seek acceptance of the drug into the market (Jarow et al., 2016). In the final step, it will be important to take into account the issuance of informed consent to seek permission from potential consumers.

References

Jarow, J. P., Lemery, S., Bugin, K., Khozin, S., & Moscicki, R. (2016). Expanded access of investigational drugs: the experience of the center of drug evaluation and research over a 10-year period. Therapeutic innovation & regulatory science, 50(6), 705-709.

Rosenblatt, M., & Kuhlik, B. (2015). Principles and challenges in access to experimental medicines. Jama, 313(20), 2023-2024.